Latham & Watkins Advises on Minerva Surgical’s Initial Public Offering

Minerva Surgical, Inc. (Minerva Surgical), a women's health company focused on the treatment of Abnormal Uterine Bleeding (AUB), has announced the pricing of its initial public offering of 6,250,000 shares of its common stock at a public offering price of US$12 per share. All of the shares are being offered by Minerva Surgical. The gross proceeds of the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Minerva Surgical, are expected to be US$75 million. The shares are traded on the Nasdaq Global Market under the ticker symbol UTRS. 

Latham & Watkins represents the underwriters in the transaction with a corporate deal team led by Orange County partner Shayne Kennedy and Bay Area partner Brian Cuneo with Orange County associate Gregory Van Buiten and Bay Area associate Josh Landis. Advice was also provided on intellectual property matters by San Diego counsel Darryl Steensma, with associate Robert Yeh; on benefits and compensation matters by Los Angeles partner Michelle Carpenter, with associate Harrison Taylor; on tax matters by Century City partner Sam Weiner, with Orange County associates Peter Bassine and Ryan Brenner; on regulatory matters by Washington, D.C. partner Elizabeth Richards and Bay Area counsel Betty Pang, with Washington, D.C. associate Chad Jennings: on data privacy matters by Bay Area counsel Heather Deixler; and on European-related matters by Paris partner Eveline Van Keymeulen, with associate Jeanne Fabre.